ARVN
ARVN
NASDAQ · Pharmaceuticals

Arvinas Inc

$10.06
-0.20 (-1.95%)
As of May 9, 1:41 AM ET ·
Analyst Consensus
Buy
26
Analysts
High
Coverage
Buy 16 62%
Hold 9 35%
Sell 1 4%
Price Target
Analyst Price Target +558.3% upside
Low Target $44.47
Average Target $66.22
High Target $75.30
Current Price $10.06
Current
$10.06
Target
$66.22
$44.47 $66.22 avg $75.30
Scenario Analysis
Bear Case
$44.47
342.0%
Low target
Base Case
$66.22
+558.3%
Avg target
Bull Case
$75.30
+648.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$14.51
-30.7% from high
52-Week Low
$5.90
+70.5% from low
Target vs 52W High
$66.22
+356.4% vs high
Next Earnings Report
May 12, 2026 · Before Market Open
1d
tomorrow
EPS Est: $-0.94
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%